Literature DB >> 25173498

Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.

Melissa Cunningham1, Natalia Marks2, April Barnado1, Jena R Wirth1, Gary Gilkeson1, Margaret Markiewicz1.   

Abstract

Microparticles (MPs) are membrane-bound vesicles with important physiologic effects. MPs exchange information intercellularly, with each kind of MP carrying antigens and receptors of the cells from which they originated. They are biologic effectors in inflammation, angiogenesis, vascular injury, and thrombosis. Thrombosis is generally caused by abnormalities in blood flow, blood composition, and/or properties of the vessel wall. Thrombosis is a well-described feature of cardiovascular disease and cerebrovascular disease. Accumulating evidence suggests that increased risk of thrombosis is also characteristic of autoimmune disorders and immune-mediated diseases affecting all age groups, although the older adults are most vulnerable. Current research has also implicated MPs as a source of autoantigenic nuclear material that can form immune complexes, activate the innate immune system, and may lead to autoimmunity. This review focuses on the contribution of MPs to both the pathogenesis of autoimmune diseases and, as the immune and coagulation systems are tightly linked, their role in hypercoagulability in the setting of autoimmunity in an aging population. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 25173498      PMCID: PMC4535344          DOI: 10.1055/s-0034-1387924

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  97 in total

Review 1.  Microparticles as mediators of cellular cross-talk in inflammatory disease.

Authors:  Jörg H W Distler; Lars C Huber; Steffen Gay; Oliver Distler; David S Pisetsky
Journal:  Autoimmunity       Date:  2006-12       Impact factor: 2.815

Review 2.  Nitric oxide insufficiency, platelet activation, and arterial thrombosis.

Authors:  J Loscalzo
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

3.  Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus.

Authors:  Anirudh J Ullal; Charles F Reich; Megan Clowse; Lisa G Criscione-Schreiber; Martin Tochacek; Marc Monestier; David S Pisetsky
Journal:  J Autoimmun       Date:  2011-03-03       Impact factor: 7.094

4.  Red blood cell microparticles and blood group antigens: an analysis by flow cytometry.

Authors:  Giorgia Canellini; Olivier Rubin; Julien Delobel; David Crettaz; Niels Lion; Jean-Daniel Tissot
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 5.  Microparticles in physiological and in pathological conditions.

Authors:  Maria Augusta Roos; Luisa Gennero; Tetyana Denysenko; Stefano Reguzzi; Giovanni Cavallo; Gian Piero Pescarmona; Antonio Ponzetto
Journal:  Cell Biochem Funct       Date:  2010-10       Impact factor: 3.685

6.  Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.

Authors:  Marie E Holmqvist; Martin Neovius; Jonas Eriksson; Ängla Mantel; Solveig Wållberg-Jonsson; Lennart T H Jacobsson; Johan Askling
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

7.  Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells.

Authors:  Anat Aharon; Tal Tamari; Benjamin Brenner
Journal:  Thromb Haemost       Date:  2008-11       Impact factor: 5.249

8.  Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome.

Authors:  Tetsuya Ueba; Takane Haze; Masaki Sugiyama; Mami Higuchi; Hitoshi Asayama; Yoshihiro Karitani; Tomofumi Nishikawa; Kohsuke Yamashita; Shuhei Nagami; Takeo Nakayama; Kazushi Kanatani; Shosaku Nomura
Journal:  Thromb Haemost       Date:  2008-08       Impact factor: 5.249

9.  Unique protein signature of circulating microparticles in systemic lupus erythematosus.

Authors:  Ole Østergaard; Christoffer T Nielsen; Line V Iversen; Julia T Tanassi; Steen Knudsen; Søren Jacobsen; Niels H H Heegaard
Journal:  Arthritis Rheum       Date:  2013-10

10.  Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.

Authors:  Wei-Sheng Chung; Chiao-Ling Peng; Cheng-Li Lin; Yen-Jung Chang; Yung-Fu Chen; John Y Chiang; Fung-Chang Sung; Chia-Hung Kao
Journal:  Ann Rheum Dis       Date:  2013-08-07       Impact factor: 19.103

View more
  2 in total

Review 1.  From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders.

Authors:  Zuzanna Małgorzata Łukasik; Marcin Makowski; Joanna Samanta Makowska
Journal:  Rheumatol Int       Date:  2018-02-28       Impact factor: 2.631

2.  Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Laura Atehortúa; Mauricio Rojas; Gloria Vásquez; Carlos H Muñoz-Vahos; Adriana Vanegas-García; Rafael Andrés Posada-Duque; Diana Castaño
Journal:  Arthritis Res Ther       Date:  2019-01-23       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.